Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.03 by 133.33 percent.
- Company Dashboard
- Filings
-
Article
Mereo BioPharma Group Q1 2024 Adj EPS $(0.01)
Company Profile